![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
The daily Top 10 COVID papers |
Breast Cancer |
Free Subscription
1 Am J Pathol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Breast Cancer is free of charge.
Somatic Mutations in LRRK2 Identify a Subset of Invasive Mammary Carcinomas
Associated with High Mutation Burden.
Am J Pathol. 2020;190:2478-2482.
PubMed
Abstract available
Evaluation of breast surgical oncology complications after single agent versus
dual agent HER2 targeted neoadjuvant chemotherapy.
Am J Surg. 2020;220:1225-1229.
PubMed
Abstract available
Impact of surgical complications on patient reported outcomes (PROs) following
nipple sparing mastectomy.
Am J Surg. 2020;220:1230-1234.
PubMed
Abstract available
A decade of intraoperative ultrasound guided breast conservation for margin
negative resection - Radioactive, and magnetic, and Infrared Oh My....
Am J Surg. 2020;220:1410-1416.
PubMed
Abstract available
Exploring the Effect of Post-mastectomy complications on 5-year survival.
Am J Surg. 2020;220:1422-1427.
PubMed
Abstract available
The art of innovation: clinical development of trastuzumab deruxtecan and
redefining how antibody-drug conjugates target HER2-positive cancers.
Ann Oncol. 2020;31:430-434.
PubMed
Reconstructing tumor history in breast cancer: signatures of mutational processes
and response to neoadjuvant chemotherapy.
Ann Oncol. 2021 Jan 5. pii: S0923-7534(20)43224.
PubMed
Abstract available
A Food and Drug Administration analysis of survival outcomes comparing the
Adjuvant Paclitaxel and Trastuzumab trial with an external control from
historical clinical trials.
Ann Oncol. 2020;31:1704-1708.
PubMed
Abstract available
Tumor mutational burden and immune infiltration as independent predictors of
response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo.
Ann Oncol. 2020;31:1216-1222.
PubMed
Abstract available
European cancer mortality predictions for the year 2020 with a focus on prostate
cancer.
Ann Oncol. 2020;31:650-658.
PubMed
Abstract available
Targeted therapy for advanced salivary gland carcinoma based on molecular
profiling: results from MyPathway, a phase IIa multiple basket study.
Ann Oncol. 2020;31:412-421.
PubMed
Abstract available
ASO Author Reflections: Tailoring Axillary Surgery After Neoadjuvant Endocrine
Therapy for Breast Cancer.
Ann Surg Oncol. 2021 Jan 2. pii: 10.1245/s10434-020-09435.
PubMed
Survival Outcomes for Metaplastic Breast Cancer Differ by Histologic Subtype.
Ann Surg Oncol. 2021 Jan 2. pii: 10.1245/s10434-020-09430.
PubMed
Abstract available
ASO Author Reflections: Will Breast Cancer Screening Become Personalized?
Ann Surg Oncol. 2021 Jan 3. pii: 10.1245/s10434-020-09457.
PubMed
The Role of Oncotype DX((R)) Recurrence Score in Predicting Axillary Response
After Neoadjuvant Chemotherapy in Breast Cancer.
Ann Surg Oncol. 2021 Jan 3. pii: 10.1245/s10434-020-09382.
PubMed
Abstract available
Personalized Screening for Breast Cancer: Rationale, Present Practices, and
Future Directions.
Ann Surg Oncol. 2021 Jan 4. pii: 10.1245/s10434-020-09426.
PubMed
Abstract available
ASO Author Reflections: Clinical Importance of Histologic Subtype for Metaplastic
Breast Cancer.
Ann Surg Oncol. 2021 Jan 5. pii: 10.1245/s10434-020-09454.
PubMed
The Role of Mastectomy in De Novo Stage IV Inflammatory Breast Cancer.
Ann Surg Oncol. 2021 Jan 5. pii: 10.1245/s10434-020-09392.
PubMed
Abstract available
ASO Author Reflections: The Multidisciplinary Approach to de Novo Metastatic
Inflammatory Breast Cancer: A Combined Systemic and Locoregional Strategy.
Ann Surg Oncol. 2021 Jan 6. pii: 10.1245/s10434-020-09421.
PubMed
Prospective Registry Trial Assessing the Use of Magnetic Seeds to Locate Clipped
Nodes After Neoadjuvant Chemotherapy for Breast Cancer Patients.
Ann Surg Oncol. 2021 Jan 8. pii: 10.1245/s10434-020-09542.
PubMed
Abstract available
ASO Author Reflections: Using Tumor Genomics to Predict Axillary Response to
Chemotherapy in Breast Cancer.
Ann Surg Oncol. 2021 Jan 8. pii: 10.1245/s10434-020-09455.
PubMed
Development of New Oncolytic Virotherapy Targeting Breast Cancer Using
Coxsackievirus B3.
Anticancer Res. 2021;41:81-89.
PubMed
Abstract available
Prognostic Nutritional Index Is Superior to Neutrophil-to-lymphocyte Ratio as a
Prognostic Marker in Metastatic Breast Cancer Patients Treated With Eribulin.
Anticancer Res. 2021;41:445-452.
PubMed
Abstract available
Neo-adjuvant and/or Adjuvant Subcutaneous Trastuzumab (Herceptin((R))) in
Patients With Early HER2-positive Breast Cancer: Real World Data from a German
Observational Study - (NIS HerSCin).
Anticancer Res. 2021;41:485-496.
PubMed
Abstract available
Secondary endpoints analysis in patients with estrogen receptor-positive
metastatic breast cancer treated with everolimus and exemestane enrolled in Oral
Care-BC.
BMC Cancer. 2021;21:34.
PubMed
Abstract available
The association between ATM variants and risk of breast cancer: a systematic
review and meta-analysis.
BMC Cancer. 2021;21:27.
PubMed
Abstract available
Comparison of hybrid clones derived from human breast epithelial cells and three
different cancer cell lines regarding in vitro cancer stem/ initiating cell
properties.
BMC Cancer. 2020;20:446.
PubMed
Abstract available
Inhibition of interferon-signalling halts cancer-associated fibroblast-dependent
protection of breast cancer cells from chemotherapy.
Br J Cancer. 2021 Jan 4. pii: 10.1038/s41416-020-01226.
PubMed
Abstract available
Overall assessment system of combined mammography and ultrasound for breast
cancer screening in Japan.
Breast Cancer. 2021 Jan 2. pii: 10.1007/s12282-020-01203.
PubMed
Abstract available
Assessment of integrative non-pharmacological interventions and quality of life
in breast cancer patients using real-world data.
Breast Cancer. 2021 Jan 3. pii: 10.1007/s12282-020-01193.
PubMed
Abstract available
Relationship between MRI findings and invasive breast cancer with
podoplanin-positive cancer-associated fibroblasts.
Breast Cancer. 2021 Jan 3. pii: 10.1007/s12282-020-01198.
PubMed
Abstract available
Sentinel lymph node biopsy after introducing Twirl(R) breast markers into
suspicious lymph nodes in breast cancer patients.
Breast Cancer. 2021 Jan 3. pii: 10.1007/s12282-020-01195.
PubMed
Abstract available
STK11 loss drives rapid progression in a breast cancer patient resulting in
pulmonary tumor thrombotic microangiopathy.
Breast Cancer. 2021 Jan 2. pii: 10.1007/s12282-020-01200.
PubMed
Abstract available
Clinical benefit of treatment after trastuzumab emtansine for HER2-positive
metastatic breast cancer: a real-world multi-centre cohort study in Japan
(WJOG12519B).
Breast Cancer. 2021 Jan 2. pii: 10.1007/s12282-020-01192.
PubMed
Abstract available
Friend or foe: ABCG2, ABCC1 and ABCB1 expression in triple-negative breast
cancer.
Breast Cancer. 2021 Jan 8. pii: 10.1007/s12282-020-01210.
PubMed
Abstract available
An immune-related risk gene signature predicts the prognosis of breast cancer.
Breast Cancer. 2021 Jan 5. pii: 10.1007/s12282-020-01201.
PubMed
Abstract available
Guideline-concordant treatment predicts survival: a National Cancer Database
validation study of novel composite locoregional and systemic treatment scores
among women with early stage breast cancer.
Breast Cancer. 2021 Jan 4. pii: 10.1007/s12282-020-01206.
PubMed
Abstract available
Neoadjuvant Chemotherapy for Breast Cancer: Past, Present, and Future.
Breast Cancer (Auckl). 2020;14:1178223420980377.
PubMed
Abstract available
Significance of the Genomic Landscape of a De Novo Endocrine-Resistant Metastatic
Hormone Receptor-Positive Breast Cancer.
Breast Cancer (Auckl). 2020;14:1178223420976387.
PubMed
Abstract available
Premenopausal breast cancer is a health challenge: nutritional habits show
potential to prevent this disease.
Breast Cancer (Auckl). 2020;14:1178223420974665.
PubMed
Abstract available
Differential PD-1/LAG-3 expression and immune phenotypes in metastatic sites of
breast cancer.
Breast Cancer Res. 2021;23:4.
PubMed
Abstract available
NRG1 fusions in breast cancer.
Breast Cancer Res. 2021;23:3.
PubMed
Abstract available
High B3GALT5 expression confers poor clinical outcome and contributes to tumor
progression and metastasis in breast cancer.
Breast Cancer Res. 2021;23:5.
PubMed
Abstract available
Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating
lymphocytes and PD-L1 in early-stage breast cancer.
Breast Cancer Res. 2021;23:2.
PubMed
Abstract available
Acquired mutations and transcriptional remodeling in long-term estrogen-deprived
locoregional breast cancer recurrences.
Breast Cancer Res. 2021;23:1.
PubMed
Abstract available
Predictors and outcomes in breast cancer patients who did or did not pursue
fertility preservation.
Breast Cancer Res Treat. 2021 Jan 4. pii: 10.1007/s10549-020-06031.
PubMed
Abstract available
Fatigue, anxiety, and quality of life in breast cancer patients compared to
non-cancer controls: a nationwide longitudinal analysis.
Breast Cancer Res Treat. 2021 Jan 4. pii: 10.1007/s10549-020-06067.
PubMed
Abstract available
FOXA1 is a determinant of drug resistance in breast cancer cells.
Breast Cancer Res Treat. 2021 Jan 8. pii: 10.1007/s10549-020-06068.
PubMed
Abstract available
Comparison of the performance of four staging systems in determining the
prognosis of breast cancer among women undergoing neoadjuvant chemotherapy.
Breast Cancer Res Treat. 2021 Jan 8. pii: 10.1007/s10549-020-06077.
PubMed
Abstract available
Endocrine therapy and radiotherapy use among older women with hormone
receptor-positive, clinically node-negative breast cancer.
Breast Cancer Res Treat. 2021 Jan 9. pii: 10.1007/s10549-020-06071.
PubMed
Abstract available
The impact of ductal carcinoma in situ on health services utilization.
Breast Cancer Res Treat. 2020;182:159-168.
PubMed
Abstract available
Risk-reducing mastectomy: a case series of 124 procedures in Brazilian patients.
Breast Cancer Res Treat. 2020;181:69-75.
PubMed
Abstract available
Ultrasound characteristics of sclerosing adenosis mimicking breast carcinoma.
Breast Cancer Res Treat. 2020;181:127-134.
PubMed
Abstract available
Breast implant-associated anaplastic large cell lymphoma: emotional impact and
guidelines for psychological support.
Breast Cancer Res Treat. 2020;181:221-224.
PubMed
Abstract available
Racial differences in estrogen receptor staining levels and implications for
treatment and survival among estrogen receptor positive, HER2-negative invasive
breast cancers.
Breast Cancer Res Treat. 2020;181:145-154.
PubMed
Abstract available
Letter to the Editor regarding the publication titled "Axillary lymph node
dissection in node-positive breast cancer: are ten nodes adequate and when is
enough, enough?"
Breast Cancer Res Treat. 2021 Jan 7. pii: 10.1007/s10549-020-06064.
PubMed
Correction to: Behavior of metastatic breast cancer according to subtype.
Breast Cancer Res Treat. 2021 Jan 7. pii: 10.1007/s10549-020-06006.
PubMed
Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial
evaluating the use of HER2-targeted therapies in patients with breast cancer and
compromised heart function.
Breast Cancer Res Treat. 2021 Jan 5. pii: 10.1007/s10549-020-06053.
PubMed
Abstract available
Trends in neoadjuvant chemotherapy versus surgery-first in stage I HER2-positive
breast cancer patients in the National Cancer DataBase (NCDB).
Breast Cancer Res Treat. 2021 Jan 4. pii: 10.1007/s10549-020-06041.
PubMed
Abstract available
Is bioimpedance spectroscopy a useful tool for objectively assessing lymphovenous
bypass surgical outcomes in breast cancer-related lymphedema?
Breast Cancer Res Treat. 2021 Jan 4. pii: 10.1007/s10549-020-06059.
PubMed
Abstract available
Impact of xenobiotic-metabolizing gene polymorphisms on breast cancer risk in
South Indian women.
Breast Cancer Res Treat. 2021 Jan 4. pii: 10.1007/s10549-020-06028.
PubMed
Abstract available
Association of mammographic density measures and breast cancer "intrinsic"
molecular subtypes.
Breast Cancer Res Treat. 2021 Jan 4. pii: 10.1007/s10549-020-06049.
PubMed
Abstract available
New brain metastases after whole-brain radiotherapy of initial brain metastases
in breast cancer patients: the significance of molecular subtypes (KROG 16-12).
Breast Cancer Res Treat. 2021 Jan 4. pii: 10.1007/s10549-020-06043.
PubMed
Abstract available
Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive
metastatic breast cancer: who needs cardiac monitoring?
Breast Cancer Res Treat. 2021 Jan 4. pii: 10.1007/s10549-020-06039.
PubMed
Abstract available
Breast cancer risk factors by mode of detection among screened women in the
Cancer Prevention Study-II.
Breast Cancer Res Treat. 2021 Jan 4. pii: 10.1007/s10549-020-06025.
PubMed
Abstract available
N-myristoyltransferase proteins in breast cancer: prognostic relevance and
validation as a new drug target.
Breast Cancer Res Treat. 2021 Jan 4. pii: 10.1007/s10549-020-06037.
PubMed
Abstract available
Comparison of short-term surgical outcomes between men and women with breast
cancer: a retrospective study using nationwide inpatient data in Japan.
Breast Cancer Res Treat. 2021 Jan 5. pii: 10.1007/s10549-020-06069.
PubMed
Abstract available
Obesity-associated methylation in breast tumors: a possible link to disparate
outcomes?
Breast Cancer Res Treat. 2020;181:135-144.
PubMed
Abstract available
Mitotic score and pleomorphic histology in invasive lobular carcinoma of the
breast: impact on disease-free survival.
Breast Cancer Res Treat. 2020;181:23-29.
PubMed
Abstract available
ZNF703 gene copy number and protein expression in breast cancer; associations
with proliferation, prognosis and luminal subtypes.
Breast Cancer Res Treat. 2021 Jan 2. pii: 10.1007/s10549-020-06035.
PubMed
Abstract available
The prognostic significance of metastatic pattern in stage IV male breast cancer
at initial diagnosis: a population-based study.
Breast Cancer Res Treat. 2021 Jan 3. pii: 10.1007/s10549-020-06052.
PubMed
Abstract available
CTCs-oriented adjuvant personalized cytostatic therapy non-metastatic breast
cancer patients: continuous non-randomized prospective study and prospective
randomized controlled study.
Breast Cancer Res Treat. 2021 Jan 3. pii: 10.1007/s10549-020-06036.
PubMed
Abstract available
Oleuropein is a natural inhibitor of PAI-1-mediated proliferation in human
ER-/PR- breast cancer cells.
Breast Cancer Res Treat. 2021 Jan 3. pii: 10.1007/s10549-020-06054.
PubMed
Abstract available
Clinical significance of HER2 status in T1bN0 breast cancer: a nationwide study
from the Korean Breast Cancer Society.
Breast Cancer Res Treat. 2021 Jan 3. pii: 10.1007/s10549-020-06017.
PubMed
Abstract available
Fourth-generation chimeric antigen receptor T cells targeting folate receptor
alpha antigen expressed on breast cancer cells for adoptive T cell therapy.
Breast Cancer Res Treat. 2021 Jan 3. pii: 10.1007/s10549-020-06032.
PubMed
Abstract available
Metabolic Syndrome: does this influence breast cancer outcomes in the
triple-negative population?
Breast Cancer Res Treat. 2021 Jan 3. pii: 10.1007/s10549-020-06034.
PubMed
Abstract available
Identification of factors that influence the decision to take chemoprevention in
patients with a significant family history of breast cancer: results from a
patient questionnaire survey.
Breast Cancer Res Treat. 2021 Jan 3. pii: 10.1007/s10549-020-06046.
PubMed
Abstract available
A clinical calculator to predict disease outcomes in women with triple-negative
breast cancer.
Breast Cancer Res Treat. 2021 Jan 3. pii: 10.1007/s10549-020-06030.
PubMed
Abstract available
BRCA testing and outcomes in women with breast cancer.
Breast Cancer Res Treat. 2021 Jan 3. pii: 10.1007/s10549-020-06038.
PubMed
Abstract available
CDH2/N-cadherin and early diagnosis of invasion in patients with ductal carcinoma
in situ.
Breast Cancer Res Treat. 2020;183:333-346.
PubMed
Abstract available
"Are changes in breast density during the menstrual cycle relevant? To what?"
Breast Cancer Res Treat. 2020;183:451-458.
PubMed
Abstract available
Association between VEGF single nucleotide polymorphism and breast cancer in the
Northern China Han population.
Breast Cancer Res Treat. 2021 Jan 3. pii: 10.1007/s10549-020-06024.
PubMed
Abstract available
Association between the polymorphisms in MMP-2 and MMP-9 with adiposity and
mammographic features.
Breast Cancer Res Treat. 2020;182:169-179.
PubMed
Abstract available
Does sentinel lymph node biopsy for screening high-grade ductal carcinoma in situ
of the breast cause more harm than good?
Breast Cancer Res Treat. 2020;182:47-54.
PubMed
Abstract available
Patients' perceptions of 70-gene signature testing: commonly changing the initial
inclination to undergo or forego chemotherapy and reducing decisional conflict.
Breast Cancer Res Treat. 2020;182:107-115.
PubMed
Abstract available
Safety and efficacy of abemaciclib plus endocrine therapy in older patients with
hormone receptor-positive/human epidermal growth factor receptor 2-negative
advanced breast cancer: an age-specific subgroup analysis of MONARCH 2 and 3
trials.
Breast Cancer Res Treat. 2021 Jan 3. pii: 10.1007/s10549-020-06029.
PubMed
Abstract available
Clinical decision trees support systematic evaluation of multidisciplinary team
recommendations.
Breast Cancer Res Treat. 2020;183:355-363.
PubMed
Abstract available
Genetic mutation profile of Chinese HER2-positive breast cancers and genetic
predictors of responses to Neoadjuvant anti-HER2 therapy.
Breast Cancer Res Treat. 2020;183:321-332.
PubMed
Abstract available
External validation and modification of nomogram for predicting positive
resection margins before breast conserving surgery.
Breast Cancer Res Treat. 2020;183:373-380.
PubMed
Abstract available
Assessing preferences for receiving supportive care resources among patients seen
at a Breast Care Center.
Breast Cancer Res Treat. 2020;183:381-389.
PubMed
Abstract available
Spatial location of local recurrences after mastectomy: a systematic review.
Breast Cancer Res Treat. 2020;183:263-273.
PubMed
Abstract available
Role of breast imaging with histopathological correlation in evaluating the
response of locally advanced breast cancer to neoadjuvant chemotherapy.
Breast J. 2020;26:2272-2275.
PubMed
Response in breast vs axilla after neoadjuvant treatment and implications for
nonoperative management of invasive breast cancer.
Breast J. 2021 Jan 3. doi: 10.1111/tbj.14125.
PubMed
Abstract available
Drug shows significant early promise in early, high-risk, HR-positive,
HER2-negative breast cancer: Interim data indicate that adding abemaciclib to
hormonal therapy reduces recurrence risk.
Cancer. 2021;127:169-170.
PubMed
Tumor microenvironment promotes breast cancer chemoresistance.
Cancer Chemother Pharmacol. 2021 Jan 9. pii: 10.1007/s00280-020-04222.
PubMed
Abstract available
IL-26, a non-canonical mediator of DNA inflammatory stimulation, promotes TNBC
engraftment and progression in association with neutrophils.
Cancer Res. 2020 May 4. pii: 0008-5472.CAN-18-3825.
PubMed
Abstract available
The Influence of Cancer Molecular Subtypes and Treatment on the Mutation Spectrum
in Metastatic Breast Cancers.
Cancer Res. 2020;80:3062-3069.
PubMed
Abstract available
Targeting ACSS2 with a transition state mimetic inhibits triple-negative breast
cancer growth.
Cancer Res. 2021 Jan 7. pii: 0008-5472.CAN-20-1847.
PubMed
Abstract available
Hypoxia-induced suppression of alternative splicing of MBD2 promotes breast
cancer metastasis via activation of FZD1.
Cancer Res. 2021 Jan 5. pii: 0008-5472.CAN-20-2876.
PubMed
Abstract available
Prognostic Significance of HER2 Expression Changes Following Neoadjuvant
Chemotherapy in Saudi Patients With Locally Advanced Breast Cancer.
Clin Breast Cancer. 2020 Dec 3. pii: S1526-8209(20)30324.
PubMed
Abstract available
Severe Impact of Covid-19 Pandemic on Breast Cancer Care in Italy: A Senonetwork
National Survey.
Clin Breast Cancer. 2020 Nov 2. pii: S1526-8209(20)30271.
PubMed
Personalization of Treatment is the Way Forward in Care and Trials.
Clin Cancer Res. 2020;26:2771-2773.
PubMed
Abstract available
Inflammation mediates the development of aggressive breast cancer following
radiotherapy.
Clin Cancer Res. 2021 Jan 5. pii: 1078-0432.CCR-20-3215.
PubMed
Abstract available
Modeling breast cancer survival and metastasis rates from moderate-sized clinical
data.
Clin Exp Metastasis. 2021 Jan 3. pii: 10.1007/s10585-020-10066.
PubMed
Abstract available
Leuprorelin combined with letrozole with/without everolimus in ovarian-suppressed
premenopausal women with hormone receptor-positive, HER2-negative metastatic
breast cancer: The LEO study.
Eur J Cancer. 2020;144:341-350.
PubMed
Abstract available
Meta-analyses of phase 3 randomised controlled trials of third generation
aromatase inhibitors versus tamoxifen as first-line endocrine therapy in
postmenopausal women with hormone receptor-positive advanced breast cancer.
Eur J Cancer. 2021;145:19-28.
PubMed
Abstract available
Identification of breast cancer patients with pathologic complete response in the
breast after neoadjuvant systemic treatment by Pfob et al.
Eur J Cancer. 2021;143:178-179.
PubMed
Association between pertuzumab-associated diarrhoea and rash and survival
outcomes in patients with HER2-positive metastatic breast cancer: Exploratory
analysis from the CLEOPATRA trial.
Eur J Cancer. 2020;144:351-359.
PubMed
Abstract available
Breast density, benign breast disease, and risk of breast cancer over time.
Eur Radiol. 2021 Jan 6. pii: 10.1007/s00330-020-07490.
PubMed
Abstract available
Delineating the breast cancer immune microenvironment in the era of multiplex
immunohistochemistry/immunofluorescence (mIHC/IF).
Histopathology. 2021 Jan 5. doi: 10.1111/his.14328.
PubMed
Abstract available
Identification of novel epithelial ovarian cancer loci in Women of African
Ancestry.
Int J Cancer. 2019 Aug 30. doi: 10.1002/ijc.32653.
PubMed
Abstract available
Risk of Cardiac Disease in Breast Cancer Patients: Impact of Patient-Specific
Factors and Individual Heart Dose from Three-Dimensional Radiotherapy Planning.
Int J Radiat Oncol Biol Phys. 2021 Jan 6. pii: S0360-3016(21)00003.
PubMed
Abstract available
Risk of Hypothyroidism in Women after Radiotherapy for Breast Cancer.
Int J Radiat Oncol Biol Phys. 2021 Jan 4. pii: S0360-3016(20)34743.
PubMed
Abstract available
Immune MAL2-practice: breast cancer immunoevasion via MHC class I degradation.
J Clin Invest. 2021;131.
PubMed
Abstract available
Coronavirus Farewell.
J Clin Oncol. 2020;38:4346-4348.
PubMed
Circulating tRNA-derived small RNAs (tsRNAs) signature for the diagnosis and
prognosis of breast cancer.
NPJ Breast Cancer. 2021;7:4.
PubMed
Abstract available
Potential of ultra-high-resolution photon-counting CT of bone metastases: initial
experiences in breast cancer patients.
NPJ Breast Cancer. 2021;7:3.
PubMed
Abstract available
MCM3 upregulation confers endocrine resistance in breast cancer and is a
predictive marker of diminished tamoxifen benefit.
NPJ Breast Cancer. 2021;7:2.
PubMed
Abstract available
LncRNA RP11-19E11 is an E2F1 target required for proliferation and survival of
basal breast cancer.
NPJ Breast Cancer. 2020;6:1.
PubMed
Abstract available
Clinical, pathological, and PAM50 gene expression features of HER2-low breast
cancer.
NPJ Breast Cancer. 2021;7:1.
PubMed
Abstract available
Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a
therapeutic target for the treatment of osteolytic lesions.
Oncogene. 2021 Jan 8. pii: 10.1038/s41388-020-01603.
PubMed
Abstract available
Understanding the role of integrins in breast cancer invasion, metastasis,
angiogenesis, and drug resistance.
Oncogene. 2021 Jan 8. pii: 10.1038/s41388-020-01588.
PubMed
Abstract available
Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a
repressive partner which silences E-Cadherin to promote EMT and associates with a
pro-metastatic phenotype.
Oncogene. 2021 Jan 8. pii: 10.1038/s41388-020-01606.
PubMed
Abstract available
Chlorogenic acid induces apoptosis, inhibits metastasis and improves antitumor
immunity in breast cancer via the NFkappaB signaling pathway.
Oncol Rep. 2020 Dec 9. doi: 10.3892/or.2020.7891.
PubMed
Abstract available
Beige adipocytes contribute to breast cancer progression.
Oncol Rep. 2020 Oct 27. doi: 10.3892/or.2020.7826.
PubMed
Abstract available
Phenethyl isothiocyanate reduces breast cancer stem cell-like properties by
epigenetic reactivation of CDH1.
Oncol Rep. 2020 Nov 19. doi: 10.3892/or.2020.7860.
PubMed
Abstract available
PDL1/PD1 blockade in breast cancer: The immunotherapy era (Review).
Oncol Rep. 2020 Nov 3. doi: 10.3892/or.2020.7831.
PubMed
Abstract available
Enhancement of cisplatin sensitivity in human breast cancer MCF-7 cell line
through BiP and 14-3-3zeta co-knockdown.
Oncol Rep. 2020 Dec 14. doi: 10.3892/or.2020.7898.
PubMed
Abstract available
Associations between breast cancer survivorship and adverse mental health
outcomes: A matched population-based cohort study in the United Kingdom.
PLoS Med. 2021;18:e1003504.
PubMed
Abstract available
Modulation of Early Mitotic Inhibitor 1 (EMI1) depletion on the sensitivity of
PARP inhibitors in BRCA1 mutated triple-negative breast cancer cells.
PLoS One. 2021;16:e0235025.
PubMed
Abstract available
Divergent organ-specific isogenic metastatic cell lines identified using
multi-omics exhibit differential drug sensitivity.
PLoS One. 2020;15:e0242384.
PubMed
Abstract available
Zena Werb (1945-2020): Mourning the loss of a tissue microenvironment icon.
Proc Natl Acad Sci U S A. 2020;117:27759-27760.
PubMed
The use of hyaluronic acid hydrogel as a tumour bed marker in breast-conserving
therapy.
Radiother Oncol. 2020;152:8-13.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by